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Background.
Important improvements have been made in treatment of diseases associated with atrial fibrillation (AF), e.g. hypertension, myocardial infarction and heart failure. Incidence rates and risk factors may have changed with the ageing of the population and changing lifestyle. Currently, the risk for AF is only partially explained, possibly due to differences between older cohorts and contemporary populations.
objectives.
We investigate the incidence of AF in a contemporary cohort study in the Netherlands, together with comorbidities associated with AF and associations of AF with cardiovascular outcomes.
methods.
Incident AF was ascertained for hospital-and study electrocardiograms in 8265 participants of the Prevention of Renal and Vascular End-stage Disease (PREVEND) study in Groningen, The Netherlands.
Results.
During 9.7 ± 2.3 years of follow-up, 265 participants developed AF, resulting in overall AF incidence of 3.3 per 1,000 person years. Advancing age, male sex, antihypertensive drug use, higher body mass index, previous myocardial infarction and previous stroke were associated with AF. After multivariable adjustment, AF was associated with cardiovascular events (hazard ratio 2.24 [1.06-4 .75], p = 0.035), heart failure with either reduced or preserved ejection fraction (hazard ratio 4.52 [2.02-10 .09], p < 0.001), and all-cause mortality (hazard ratio 3.02 [1.73-5 .27], p < 0.001).
Conclusion.
Incidence of AF in the present cohort was comparable to data of older studies. Obesity has become a major risk factor for incident AF. While overall event rates were lower in the present study, the present study confirms the association of incident AF with cardiovascular events.
InTRoduCTIon
Atrial fibrillation (AF) affects millions of people worldwide, and numbers are expected to increase (1) . AF has large impact on the individual's life. It is accompanied by symptoms, impaired quality of life, increased risk of stroke, dementia, heart failure, mortality, and increasing health care expenses (2, 3) .
Multiple comorbidities have been associated with incident AF (1) . However current knowledge on AF incidence, prevalence, risk factors and associated cardiovascular morbidity and mortality is based on predominantly North-American cohort studies that were initiated a long time ago, or more-recently registries based on questionnaires or ICD discharge codes (5) (6) (7) (8) (9) (10) . In recent years important improvements were made in pharmacological and non-pharmacological treatment of associated diseases, such as hypertension, myocardial infarction and heart failure (11-13). In addition, incidence rates and risk factors may have changed with the ageing of the population and changing lifestyle. Nowadays, the risk for incident AF is only partially explained, which may be due to differences between older cohorts and more contemporary populations. We investigate the incidence of AF, comorbidities associated with AF, and the associations of AF with cardiovascular events, systolic and diastolic heart failure and all cause mortality in the Dutch community-based Prevention of Renal and Vascular End-stage Disease (PREVEND) cohort study.
meThods
Population.
The PREVEND cohort study was founded in 1997 by inviting all inhabitants of the city of Groningen, The Netherlands, aged 28 to 75 years (n = 85,421) (14) . Of all invitees, 40,856 responded (47.8%). Individuals with urinary albumin excretion (UAE) > 10 mg/L (n = 7,768) in their morning urine as well as a randomly selected control group with a UAE < 10 mg/L (n = 3,394) were invited to the PREVEND outpatient clinic. After excluding individuals with insulin-dependent diabetes mellitus, pregnant women, and individuals unable or unwilling to participate, a final cohort of 8,592 individuals was included and completed the baseline-screening program. The baseline-screening program consisted of 2 outpatient visits to assess demographics, anthropometric measurements, cardiovascular and metabolic risk factors, health behavior, and to collect blood samples and two 24-hour urine samples on 2 consecutive days. Participants were seen at 3-year intervals in the PREVEND outpatient clinic. For the present analysis, we excluded participants without any electrocardiogram (ECG) (n = 248) as well as participants with prevalent AF at the baseline screening (n = 79), leaving 8,265 participants. The PREVEND study was approved by the institutional medical Ethics Committee and conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent.
Assessment of Af.
Incident AF was diagnosed if either atrial fl utter or AF was present on a 12-lead ECG obtained at 1 of the 3 PREVEND follow-up visits, or at an outpatient visit or hospital admission in the 2 hospitals in the city of Groningen (University Medical Center Groningen and Martini Hospital). A standard 12-lead ECG was performed at each PREVEND follow-up visit. All ECGs were digitally stored, and electronically screened for the following criteria: PR interval absence, atrial fl utter, or ectopic atrial rhythm. This method of electronic screening was validated with complete manual screening by 2 independent observers of all ECGs from PREVEND baseline visit, and 100% sensitivity for the detection of AF or atrial fl utter was reached. All ECGs determined via the electronic screening with suspected AF were manually reviewed by 2 independent observers. When an inconsistency was found or when both observers agreed on the diagnosis of AF or atrial fl utter, the ECGs were validated by 2 independent cardiologists (figure 1). Incident AF was diagnosed in 265 participants. For the date of incident AF the date of the fi rst ECG with a defi nite diagnosis of AF or atrial fl utter was used. 
Covariate definitions.
Systolic and diastolic blood pressures were calculated as the mean of the last 2 measurements of the 2 visits, using an automatic Dinamap XL Model 9300 series device. Hypertension was defined as systolic blood pressure > 140 mmHg, diastolic blood pressure > 90 mmHg, or use of antihypertensive drugs. Body mass index (BMI) was calculated as the ratio of weight to height squared (kg/m2), and obesity was defined as a BMI > 30 kg/m 2 . Type 2 diabetes was defined as a fasting plasma glucose > 7.0 mmol/L (126 mg/dL), a nonfasting plasma glucose > 11.1 mmol/L, or use of anti-diabetic drugs. Urinary albumin excretion was calculated as the average value from 2 consecutive 24 h urine collections. The estimated glomerular filtration rate (eGFR) was estimated using the simplified modification of diet in renal disease formula. Smoking was defined as current nicotine use or quit smoking within the previous 5 years. Hypercholesterolemia was defined as total serum cholesterol > 6.5 mmol/L (251 mg/dL), or a serum total cholesterol ≥ 5.0 mmol/L (193/mg/dL) if a history of myocardial infarction was present, or use of lipid-lowering drugs. Alcohol consumption was defined as 4 alcoholic drinks per day or more in men, and 1-3 alcoholic drinks per day or more in women. History of myocardial infarction or stroke was defined as participant-reported hospitalization for at least 3 days as a result of this condition. Peripheral artery disease was defined as an ankle-brachial index < 0.9. A committee of heart failure experts adjudicated all participants with heart failure at baseline according to previously published criteria (14) . N-terminal prohormone of brain natriuretic peptide (NT-proBNP) and highly sensitive C-reactive protein (high sensitive CRP) were measured as described previously (15, 16) .
follow-up.
The follow-up duration was calculated as the time between the baseline-screening visit to the last contact date, death, or December 31, 2008 (end of the third PREVEND followup visit), whichever came first.
Cardiovascular events, heart failure and all cause mortality assessment.
Information on cardiovascular events was obtained from PRISMANT, the Dutch national registry of hospital discharge diagnoses. The validity of this database has been confirmed before, with 84% of primary diagnoses and 87% of secondary diagnoses matching the diagnoses recorded in participants' charts (17) . Use of hospital discharge diagnoses and government vital statistics was part of the original study design (18 . A committee of heart failure experts adjudicated all incident heart failure events according to previously published criteria, and categorized, based on the left ventricular ejection fraction (LVEF) and diastolic dysfunction, into either heart failure with reduced ejection fraction (LVEF < 40%) and heart failure with preserved ejection fraction (LVEF > 50%) (2) . Six heart failure participants had a LVEF of 41-49%. These were included in the total number of heart failure patients, but were not involved in analyses specifi c for this group because of the low number of events. There was no classifi cation made based on underlying cause, since many heart failure patients have more than one comorbidity. Data on mortality were obtained through the municipal registration. Cause of mortality was ascertained by linking the number of the mortality certifi cate to the primary cause of mortality as coded by the Dutch Central Bureau of Statistics. Information on dates and causes of death for every participant was obtained from Statistics Netherlands (19), according to the 10th revision of the ICD.
statistical analysis.
We used a statistical weighting method to adjust for the oversampling of individuals with microalbuminuria at study start, and to allow generalization of results to the general population (16) . Participant characteristics were presented as mean ± standard deviation or median (range) for continuous variables and counts with percentages for categorical variables. Incidence rates for the number of AF cases or outcome events/1,000 person-years of observation and 95% confi dence intervals were calculated (20) . We estimated multivariable Cox proportional-hazards regression models to assess risk factors for incident AF during follow-up; death was considered a censoring event. We examined the proportionality assumption by calculating the Schoenfeld residuals, and by plotting the scaled Schoenfeld residuals against time. There were no violations of the proportional-hazards assumption. We selected risk factors for the incident AF analyses based on prior reports and availability in clinical practice (11, 12) . Age-and sex-adjusted covariates with a p < 0.1 were stepwise incorporated in a multivariable-adjusted model, the order based on the highest Wald statistic. The fi nal multivariable model included all covariates with p < 0.05. Finally, interactions in the multivariate model were tested. In view of multiple testing, we applied a Bonferroni correction to the interaction analysis, in order to minimize false-positive fi ndings. Population attributable risks for reversible or treatable risk factors in the multivariate model were calculated using the formula: ([total AF incidence rate -unexposed AF incidence rate]/[total AF incidence rate]) x 100% (21). We used Cox time-dependent regression analyses, with AF as time-varying covariate to study the association of incident AF and future cardiovascular events, heart failure and all cause mortality. We adjusted for clinically signifi cant covariates, based on prior publications (22) (23) (24) . In Model 1 we adjusted for age and sex, and in Model 2 we adjusted for age, sex, heart failure, antihypertensive drug use, diabetes, previous stroke, previous myocardial infarction, peripheral artery disease, and NT-proBNP. All analyses were performed using R package (version 3.0.3) and a 2-tailed p-value < 0.05 was considered statistically signifi cant.
A Figure 1A . B.
Figure 2. Atrial fi brillation incidence in PREVEND study.
A: Incidence rate of atrial fi brillation as a function of age for men and women. The 95% confi dence intervals are shown using error bars. B: Cumulative incidence rate of AF as a function of age for men and women. The black line is the (smoothed) cumulative incidence rate curve for men; the grey line for women. The 95% confi dence intervals are shown using shaded areas. The cumulative incidence rate at a given age is the incidence rate of atrial fi brillation in the group of all people younger than the given age. Participants with incident AF were 62 ± 9 years of age and 70% were men. Of the 265 participants with incident AF, 60 (23%) were diagnosed at a PREVEND visit, the other 205 (77%) at hospital visit or admission. Both cumulative and non-cumulative incidence rates for incident AF stratified by age and sex demonstrated higher AF incidence rates in 
Data is expressed as mean±standard deviation (SD), median (IQR) or numbers (%).
Abbreviations: BMI = body mass index; CRP = C-reactive protein; eGFR = estimated glomerular filtration rate; NTproBNP = N-terminal prohormone of brain natriuretic peptide; UAE = 24-hour urine albumin excretion.
older individuals ( figure 2A and B) . Primary comorbidities in participants with incident AF were hypertension (54%), obesity (23%), and previous myocardial infarction (15%).
Risk factors for incident Af.
Age-and sex-adjusted analyses revealed that higher BMI, higher systolic blood pressure, antihypertensive drug use, previous myocardial infarction, heart failure, previous stroke, lower heart rate, and higher NT-proBNP were associated with an increased risk of incident AF ( Table 2) . After stepwise addition of covariates, the final multivariable model consisted of 6 covariates (Central Illustration): advancing age, male sex, BMI, antihypertensive drug use, previous myocardial infarction, previous stroke. There were no significant interactions in the multivariate model. Population attributable risk estimates for the most significant reversible or treatable risk factors for incident AF were calculated: The risk factor that contributed most to incident AF in the present population was antihypertensive drug use (32%), followed by previous myocardial infarction (16%), obesity (9%) and previous stroke (3%).
Associations of Af with cardiovascular events, heart failure and all cause mortality.
Incidence rates of cardiovascular outcomes for participants with and without incident AF are described in Abbreviations: BMI = body mass index; NT-proBNP =N-terminal prohormone of brain natriuretic peptide. *Composite of cardiovascular events, some participants had multiple events. †Six heart failure participants had a LVEF of 41-49%. To ensure a clear distinction between both systolic and diastolic heart failure these participants were not shown in the table. Abbreviations: LVEF = left ventricular ejection fraction.
dIsCussIon
The present contemporary community-based study in the Netherlands had 3 primary findings. First, the AF incidence in the present population was 3.3 per 1,000 person years, and comparable to that in older epidemiological studies. Second, in addition to the conventional risk factors for AF, BMI was strongly associated with AF. Third, we confirmed that AF, despite lower overall event rates, is associated with an adverse outcome.
Incidence of Af.
In the present study, we identified 265 participants with incident AF, and the overall incidence rate of AF was 3.3 per 1,000 person years. AF incidence was higher in men than in women, and there was a strong increase with age, which is comparable to other studies (5) (6) (7) (8) 25 ). The incidence is lower than observed in the Rotterdam Study, also from the Netherlands, where the overall incidence rate of AF was 9.9 per 1,000 person years. This is probably caused by the age difference of included individuals (in Rotterdam > 55 years, in PREVEND between 28 and 75 years) (25) ( [5] [6] [7] [8] 25) . This is an interesting finding, because continuously improvements are made in the treatment of cardiovascular risk factors for AF including hypertension, coronary heart disease, and heart failure (11) (12) (13) . Whereas improved treatment of cardiovascular diseases may reduce the risk of development of AF, on the contrary, the improved life expectancy, changes in lifestyle such as inactivity and obesity, may increase the incidence of AF. Together, this may have resulted in an AF incidence in the present study being comparable to older studies.
Comorbidities associated with incident Af.
Most data on comorbidities associated with AF in the general population have been obtained from old American cohorts starting their inclusion before the introduction of contemporary treatments for myocardial infarction, hypertension and heart failure, and increasing availability of diagnostic tests, and changing lifestyle (11) (12) (13) 26) . Associations of advancing age, male sex, hypertension, coronary heart disease, valve disease, heart failure and diabetes mellitus with incident AF have been well established (4, 6, 7, 21, 25) . In the present contemporary Dutch cohort we found similar associations of well-established risk factors. In addition, obesity was an important contributor to AF risk. In a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference published in 2011 (12) , BMI was considered a less-validated risk factor for AF. However, with a 45% increased risk of AF with every 5 points of BMI increase, the present study supports the notion that BMI should be regarded as a validated risk factor for AF.
Obesity often co-exists with other cardiovascular risk factors and diseases,e.g. diabetes, metabolic syndrome, and the sleep apnea syndrome. However, obesity by itself may also induce AF. Animal models of obesity showed the induction of cardiac ectopic fat and fat infiltration of the local atrial myocardium, potentially a novel substrate specific to obesity (3) . Importantly, obesity is a modifiable risk factor, and it has been recently shown that strict weight reduction reduced the AF burden (29) . The population attributable risk of obesity in this study provides an indication that 9% reduction of incident AF could be achieved when the risk factor obesity was completely eliminated.
Af related cardiovascular events, heart failure and mortality.
The present analysis confirms the association of AF with adverse outcomes, including cardiovascular events, heart failure and all cause mortality. Treatment of AF has significantly changed during the last decade. The most important change has been systematic use of oral anticoagulation in individuals at risk for stroke (4) . While the overall event rates were lower in the present contemporary cohort, the associations with outcome were similar as previously described. The lower rates of cardiovascular events, heart failure and all cause mortality may be caused by improved treatment modalities. However, incident AF was still associated with a 2-fold increase of cardiovascular events including stroke, a 5-fold increased heart failure risk, and a 2-fold increased risk of all cause mortality, largely similar to associations found previously (23, 24) . Despite the important improvements in oral anticoagulation reducing the risk of stroke (30) (31) (32) , the risk of heart failure and all cause mortality associated with AF are still high (24) . Next to stroke prevention, more focus on prevention of heart failure and mortality in individuals with AF seems important in the years to come, to further improve prognosis of those with AF.
strengths and limitations.
Strengths of our study are the contemporary cohort, the detailed clinical assessment, the long and contemporary follow-up period, and the robust validation of cardiovascular events, including AF. However, there are limitations, mainly due to the observational design of this community-based cohort study. We may have overlooked asymptomatic paroxysmal AF, since we had no continuous ECG recordings (33) . And since an event was only attributed to AF when AF was diagnosed before the event occurred, the present event rates may be underestimated. Stroke was defined using ICD codes for occlusion or stenosis of the precerebral or cerebral arteries; no direct evaluation for stroke was performed. Data on obstructive sleep apnea was not available. Although treating physicians were informed about presence of AF or other undiagnosed cardiovascular diseases, treatment was left to discretion of the physician.
ConClusIons
Results of our contemporary community-based study from the Netherlands confirm that although important progress in treatment of cardiovascular disease is continuously being made, AF incidence has not dramatically changed over the years. Obesity has become a major risk factor for incident AF. While overall event rates were lower in the present study, incident AF still doubles the cardiovascular event risk, all cause mortality risk and increases the heart failure risk 5-fold. Identification and improved treatment of reversible risk factors for incident AF, and prevention of heart failure and mortality, may avoid AF and improve AF prognosis.
PeRsPeCTIVes
Competency in medical knowledge.
Despite considerable progress in management of cardiovascular disease, the incidence of AF has not decreased and this common rhythm disturbance is associated with ad-verse cardiovascular outcomes, including heart failure and stroke. In addition to wellestablished factors, obesity has become a risk factor for AF.
Translational outlook.
More research should be directed toward understanding the roles of weight reduction and lifestyle modification in prevention of AF.
